Search Results for "drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for drug. Results 1061 to 1070 of 2606 total matches.

Isosorbide Mononitrate for Angina

   
The Medical Letter on Drugs and Therapeutics • Jun 26, 1992  (Issue 873)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Isosorbide mononitrate (ISMN; Ismo - Wyeth-Ayerst), an oral nitrate long available in Europe, was recently approved by the US Food and Drug Administration for prophylactic use in patients with chronic stable angina. ISMN is the major active metabolite of isosorbide dinitrate (ISDN; Isordil, and others).
Med Lett Drugs Ther. 1992 Jun 26;34(873):61 |  Show IntroductionHide Introduction

Rifaximin (Xifaxan 550) for Hepatic Encephalopathy

   
The Medical Letter on Drugs and Therapeutics • Nov 01, 2010  (Issue 1350)
The Medical Letter® On Drugs and Therapeutics Volume 52 (Issue 1350) November 1, 2010 ...
The FDA has approved a new 550-mg tablet of rifaximin (Xifaxan – Salix), a minimally absorbed oral antibiotic, to reduce the risk of recurrent hepatic encephalopathy (HE). A 200-mg tablet has been available for treatment of travelers’ diarrhea since 2004.
Med Lett Drugs Ther. 2010 Nov 1;52(1350):87 |  Show IntroductionHide Introduction

In Brief: Anktiva for Bladder Cancer (online only)

   
The Medical Letter on Drugs and Therapeutics • Jun 24, 2024  (Issue 1705)
inbakicept with other drugs used for treatment of NMIBC are available. ADVERSE EFFECTS — Dysuria, hematuria ...
Nogapendekin alfa inbakicept-pmln (Anktiva – ImmunityBio), a first-in-class interleukin-15 (IL15) receptor agonist, has been approved by the FDA for use with Bacillus Calmette-Guérin (BCG) for treatment of patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ with or without papillary tumors. Such patients generally undergo bladder tumor resection, followed by intravesical BCG treatment, but treatment failure and cancer recurrence are common. The adenoviral vector-based intravesical gene therapy nadofaragene firadenovec-vncg (Adstiladrin)...
Med Lett Drugs Ther. 2024 Jun 24;66(1705):e105-6   doi:10.58347/tml.2024.1705e |  Show IntroductionHide Introduction

FK 506 - An Investigational Immunosuppressant

   
The Medical Letter on Drugs and Therapeutics • Oct 04, 1991  (Issue 854)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
FK 506 (Fujisawa), an immunosuppressant similar in activity to cyclosporine (Sandimmune - Medical Letter 25:77, 1983), is currently under investigation in the USA, Europe, and Japan for prevention of organ transplant rejection.
Med Lett Drugs Ther. 1991 Oct 4;33(854):94 |  Show IntroductionHide Introduction

Interferon Beta-1a for Relapsing Multiple Sclerosis

   
The Medical Letter on Drugs and Therapeutics • Jul 19, 1996  (Issue 979)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Interferon β-1a (Avonex - Biogen), a recombinant form of human interferon β, has been approved by the US Food and Drug Administration (FDA) for treatment of relapsing forms of multiple sclerosis (MS). Interferon β-1a (Betaseron - Berlex), a recombinant analog of interferon β that differs from interferon β-1a in having a serine substituted for a cysteine and in not being glycosylated, was previously approved for this indication (Medical Letter, 35:61, 1993; BW van Oosten et al, Drugs, 49:200, 1995).
Med Lett Drugs Ther. 1996 Jul 19;38(979):63-4 |  Show IntroductionHide Introduction

Arbutamine for Stress Testing

   
The Medical Letter on Drugs and Therapeutics • Jan 30, 1998  (Issue 1019)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Myocardial perfusion imaging and stress echocardiography in patients who cannot exercise may require use of drugs. Arbutamine (GenESA - Gensia Automedics), a potent synthetic sympathomimetic, has recently been approved by the FDA for use with a computerized drug-delivery system in pharmacologic stress testing.
Med Lett Drugs Ther. 1998 Jan 30;40(1019):19-20 |  Show IntroductionHide Introduction

Once-a-week Alendronate (Fosamax)

   
The Medical Letter on Drugs and Therapeutics • Mar 19, 2001  (Issue 1100)
The Medical Letter  On Drugs and Therapeutics Published by The Medical Letter, Inc. • 1000 Main ...
Once-a-week formulations of alendronate (Fosamax) in 35- and 70-mg tablets have now been approved by the FDA and are being heavily promoted for prevention and treatment of postmenopausal osteoporosis. A new formulation of risedronate (Actonel) for once-a-week use is under development and may be available next year.
Med Lett Drugs Ther. 2001 Mar 19;43(1100):26 |  Show IntroductionHide Introduction

In Brief: Plan B OTC

   
The Medical Letter on Drugs and Therapeutics • Sep 11, 2006  (Issue 1243)
Letter ® On Drugs and Therapeutics Volume 48 (Issue 1243) September 11, 2006 www.medicalletter.org ...
The FDA has approved over-the-counter (OTC) sales of Plan B (Duramed), an emergency contraceptive package that contains two 0.75-mg tablets of levonorgestrel, to women ≥18 years old. Younger women still require a prescription. In one trial, two levonorgestrel 0.75-mg tablets taken 12 hours apart, the first within 72 hours after unprotected intercourse, decreased the pregnancy rate to 1%, compared to an expected rate of 8% (Task Force on Postovulatory Methods of Fertility Regulation, Lancet 1998; 352:428). How high doses of a progestin taken after coitus prevent pregnancy is unclear; they may...
Med Lett Drugs Ther. 2006 Sep 11;48(1243):75 |  Show IntroductionHide Introduction

Correction: Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures

   
The Medical Letter on Drugs and Therapeutics • Dec 17, 2007  (Issue 1276)
Letter ® On Drugs and Therapeutics Volume 49 (Issue 1276) December 17, 2007 www.medicalletter.org ...
On page 100 of the article "Major Changes in Endocarditis Prophylaxis for Dental, GI and GU Procedures", under the section Highest-Risk Procedures, the word "rubber" should have been omitted. Placement of orthodontic rubber bands is not a highest-risk procedure that justifies prophylaxis; placement of orthodontic (metal) bands is. An orthodontic band is a metal ring that surrounds the tooth and is pressed into place causing movement in closely-spaced teeth and sometimes bleeding when the bands are placed close to the gumline.
Med Lett Drugs Ther. 2007 Dec 17;49(1276):104 |  Show IntroductionHide Introduction

Nonstandard Uses of Chelation Therapy

   
The Medical Letter on Drugs and Therapeutics • Sep 20, 2010  (Issue 1347)
The Medical Letter® On Drugs and Therapeutics Volume 52 (Issue 1347) September 20, 2010 ...
Chelation therapy involves oral administration, intravenous infusion or intramuscular injection of drugs that increase excretion of heavy metals. The Medical Letter’s last article on this subject found no evidence that it was effective for treatment of cardiovascular disease. Since then, off-label use of chelation therapy has expanded to include treating children with autism and adults with Alzheimer’s disease, cancer and other chronic diseases.

Click here to view the free full article.
Med Lett Drugs Ther. 2010 Sep 20;52(1347):75-6 |  Show IntroductionHide Introduction